Tipping Point: Tariffs Create Uncertainty, Risk Long-Term Price Increases, Shortages

 
• By Sue Sutter
  
Egg on table edge
The 10% tariff on API from China, if it lasts, could push some generic drug manufacturers out of some markets. (Shutterstock)

More from Distribution/Supply Chain

More from Biosimilars & Generics